A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...
Dexcom pushed back on claims in a Food and Drug Administration warning letter that the company made unauthorized changes to its glucose sensors ... major changes to its devices without submitting ...
Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...
Zacks.com on MSN6d
DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 ApprovalDexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The ...
The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need ... for one two-week sensor and £300 for four. There are more than 25 million ...
Zacks Investment Research on MSN2d
DXCM Inks Deal With Nanowear to Boost CGM Application Beyond DiabetesDexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use glucose ...
An alleged prototype of the Apple Watch Series 10 has a brand new sensor that may have been intended for blood sugar ...
An eighth grader from Andover turned a personal moment into an invention that could bring peace of mind to those with ...
As per a clinical study, smartwatches can help drive meaningful exercise routines and lifestyle changes to help people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback